Skip to main content
Retour
Watch Compare

Longevity Health Holdings, Inc.

Qualité des données : 100%
Également cotée sous XAGEW OTC
XAGE
OTC Manufacturing Chemicals
0,27 €
▼ 0,01 € (-3,60%)
Cap. Boursière: 663 386,0
Prix
0,27 €
Cap. Boursière
663 386,0
Fourchette du Jour
0,30 € — 0,39 €
Fourchette 52 Semaines
0,23 € — 9,30 €
Volume
12 899
Ouverture 0,39 €
Moyenne 50J / 200J
0,31 €
13,60% below
Moyenne 50J / 200J
1,19 €
77,43% below

Quick Summary

Points Clés

Negative free cash flow of -3,34 M
Capital efficient — spends only 0,74% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)3701,44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-361,00%
Op. Margin-371,58%

Sécurité

Debt / Equity
N/A
Current Ratio0,42
Interest Coverage-390,23

Valorisation

PE (TTM)
-0,10
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -361,0 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 3701,44% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,91 M Net Income (TTM) -6,91 M
ROE N/A ROA -196,78%
Gross Margin 57,23% Operating Margin -371,58%
Net Margin -361,00% Free Cash Flow (TTM) -3,34 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,42
Interest Coverage -390,23 Asset Turnover 0,55
Working Capital -4,00 M Tangible Book Value -3,99 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,10 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -504,00%
Market Cap 663 386,0 Enterprise Value 663 386,0
Per Share
EPS (Diluted TTM) -4,83 Revenue / Share 0,77
FCF / Share -1,35 OCF / Share -1,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,74% FCF Conversion 48,42%
SBC-Adj. FCF -4,03 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue 1,91 M 50 318,0 — — —
Net Income -6,91 M -10,37 M -15,45 M -329 382,0 204 997,0
EPS (Diluted) -4,83 -0,49 -1,46 — —
Gross Profit 1,09 M 43 961,0 — — —
Operating Income -7,11 M -5,00 M -5,94 M -467 431,0 -1,65 M
EBITDA — — — — —
R&D Expenses 788 888,0 1,05 M 2,50 M — —
SG&A Expenses — — — — —
D&A 78 675,0 83 486,0 97 113,0 — —
Interest Expense 18 214,0 29 446,0 — — —
Income Tax 36 262,0 -97 279,0 0,0 0,0 391 198,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 2,37 M 1,47 M 63,95 M 155,42 M 156,98 M
Total Liabilities 8,23 M 6,19 M 39,20 M 5,74 M 7,09 M
Shareholders' Equity -5,87 M -4,71 M 24,75 M -4,76 M -6,02 M
Total Debt — — — — —
Cash & Equivalents 706 740,0 — 2,91 M 774 192,0 —
Current Assets 1,95 M 955 554,0 62,90 M 973 175,0 285 202,0
Current Liabilities 7,92 M 5,88 M 38,50 M 330 007,0 1,68 M